<DOC>
	<DOCNO>NCT01365104</DOCNO>
	<brief_summary>The purpose study determine iron chelator , desferrioxamine increase blood level hypoxia-inducible transcription factor 1 ( HIF-1 protein ) see correspond increase blood flow brain .</brief_summary>
	<brief_title>Modulation Cerebral Blood Flow Using Iron Chelators</brief_title>
	<detailed_description />
	<mesh_term>Deferoxamine</mesh_term>
	<criteria>healthy adult age 1880 year . subject take vasoactive medication , hypertension , pregnant woman , smoker , COPD , asthma , diabetes mellitus , intracranial carotid stenosis , hepatic disease , renal disease , bone marrow suppression , cardiac disease , heart failure , iron deficiency , history cancer , history head trauma , subarachnoid hemorrhage , central nervous system vasculitis , multiple sclerosis , migraine , seizure , sickle cell disease trait , cardiac arrhythmia , unable give inform consent , poor transcranial Doppler insonation window .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2015</verification_date>
	<keyword>brain blood flow</keyword>
	<keyword>stroke</keyword>
	<keyword>cerebrovascular</keyword>
	<keyword>age</keyword>
	<keyword>cerebrovascular hemodynamics</keyword>
</DOC>